# The Efficacy and Safety of Atock Dry Syrup With Acute Bronchitis Patients

> **NCT06411925** · PHASE4 · RECRUITING · sponsor: **SamA Pharmaceutical Co., Ltd** · enrollment: 296 (estimated)

## Conditions studied

- Acute Bronchitis

## Interventions

- **DRUG:** Atock Dry Syrup with placebo patch
- **DRUG:** Tulobuterol patch with placebo dry syrup

## Key facts

- **NCT ID:** NCT06411925
- **Lead sponsor:** SamA Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-10
- **Primary completion:** 2027-07
- **Final completion:** 2027-09
- **Target enrollment:** 296 (ESTIMATED)
- **Last updated:** 2025-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06411925

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06411925, "The Efficacy and Safety of Atock Dry Syrup With Acute Bronchitis Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06411925. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*